maining nutrients are sufficient to maintain cell survival and cell growth. In this work, we demonstrate that glucose availability directly regulates cell proliferation and
To test whether AMPK is activated at levels of extracellular glucose that impair mammalian cell proarrest in response to AMPK activation and continue to proliferate under low-glucose conditions, leading to a liferation, we measured the level of AMPK activation in MEFs cultured under low-glucose conditions (1 mM). rapid decline in cell viability. Activation of AMPK leads to phosphorylation of p53 at serine 15 (serine 18 of Both the phosphorylation status and the activity of AMPK increased as cells were cultured in reduced glumouse p53), and this phosphorylation event is essential for mediating the effects of AMPK on p53-dependent cose ( Figure 1C ). AMPK became phosphorylated on Thr-172, and increased Ser-79 phosphorylation of the cell-cycle arrest. These findings indicate that AMPK is a cell-intrinsic metabolic sensor that couples glucose AMPK substrate acetyl CoA carboxylase (ACC) was observed when cells were cultured at 1 mM glucose. availability to the cell-cycle machinery of a proliferating cell. This discovery highlights a previously unappreciAs an initial test of the role of AMPK activation in the cellular response to decreased glucose availability, we ated relationship between glucose metabolism and cell proliferation and implicates p53 as an essential compotreated cells in glucose-replete medium with the AMPK activator 5-aminoimidazole-4-carboxamide riboside nent of metabolic cell-cycle control.
(AICAR). Even in 25 mM glucose, AICAR-treated cells failed to accumulate ( Figure 1D) . G 0 /G 1 -arrested MEFs Results also exhibited a dose-dependent block in the G 1 to S progression when stimulated with serum in the presGlucose Limitation Restricts Cell-Cycle Progression ence of AICAR ( Figure 1E ). Whether the availability and metabolism of specific nutrients contributes to control of the mammalian cell cyGlucose Restriction Induces Activation of a Reversible Cell-Cycle Checkpoint cle is not known. Here we investigated the effects of glucose limitation on cell proliferation in otherwise One mechanism that can limit cell accumulation in proliferating cultures is the induction of apoptotic cell complete medium. Primary mouse embryonic fibroblasts (MEFs) cultured in medium containing 1 mM gludeath. Glucose depletion has been reported to induce apoptosis through activation of the proapoptotic molecose accumulated at a lower rate than cells incubated in full-glucose media (25 mM glucose) ( Figure 1A ).
cule Bax (Rathmell et al., 2003) . However, significant levels of apoptosis were not observed at concentraWhen serum-deprived cells were induced to reenter the cell cycle, their ability to traverse the G 1 /S boundary tions of extracellular glucose that induce a near com- plete cell-cycle arrest. Apoptotic cell death was ob-TSC2-dependent pathway (Inoki et al., 2003) . A reduced translation rate could lead to prolongation of the served only when cells were transferred to medium completely deficient in glucose (Figure 2A) . G 1 phase of the cell cycle by reducing the rate of cell growth that normally accompanies proliferation. To asRecent evidence has demonstrated that ATP depletion can suppress cell growth by inhibiting protein sess whether glucose depletion alone affects cell growth, we measured the cell size of MEFs cultured translation, a process initiated by an AMPK-TSC1-under low-glucose conditions. Surprisingly, when MEFs were switched into medium containing low glucose for 24 hr, they exhibited a larger cell size than cells maintained in standard medium, even though they underwent a cell-cycle arrest ( Figure 2B ).
To test whether the size increase induced by glucose limitation was regulated by the activity of mTOR, we analyzed the growth of glucose-restricted cells in the presence of the TOR inhibitor rapamycin. Treatment with rapamycin completely suppressed the size increase observed when cells were cultured in low glucose in the presence of a full complement of amino Figure 6A ). In addition, p53-dependent tranp53 under low-glucose conditions. In contrast, Ser-18 phosphorylation in response to low glucose was scription was strongly induced by active AMPK in wildtype MEFs (p53 +/+ ) ( Figure 6B ). p53 is activated in blocked by dominant-negative AMPK ( Figure 6G ). The biological importance of Ser-18 phosphorylation in the response to cellular stress in part through posttranslational modifications that promote its stabilization (Vop53-dependent response to glucose limitation was determined using MEFs harboring a germline knock-in gelstein et al., 2000). The motif surrounding serine 15 of p53 (serine 18 in mouse), a site known to undergo mutation that converts Ser-18 of mouse p53 to alanine (denoted p53 S18A/S18A ) (Chao et al., 2000) . While MEFs phosphorylation during p53 activation, is similar to the motif on ACC phosphorylated by AMPK (Figure 6C) , wild-type for p53 were unable to proliferate under lowglucose conditions, p53 S18A/S18A MEFs displayed a proraising the possibility that this site is also targeted by AMPK kinase activity. Treatment of 293T cells with liferative rate nearly identical to that of p53 null cells ( Figure 6H ). AICAR promoted a dose-dependent increase in p53 phosphorylation at Ser-15 ( Figure 6D) , consistent with Finally, to assess whether AMPK-dependent p53 phosphorylation is required for AMPK-induced cellprevious observations (Imamura et al., 2001 ). To test whether phosphorylation of p53 at this residue is medicycle arrest, the ability of AMPK to induce cell-cycle arrest in p53 S18A/S18A MEFs was examined. In contrast ated by the activity of AMPK, p53 null H1299 cells were cotransfected with CA-AMPK and mouse p53 (Figure to wild-type MEFs in which CA-AMPK induces a proliferative arrest, p53 S18A/S18A mutant MEFs expressing 6E). Coexpression of CA-AMPK with p53 promoted phosphorylation of p53 at Ser-18, confirming that CA-AMPK failed to undergo cell-cycle arrest and proliferated at a similar rate to controls ( Figure 6I ). AMPK activity was sufficient to induce this phosphorylation event. Coexpression of CA-AMPK and p53 also led to a synergistic increase in endogenous p21 prop53 Controls AMPK-Induced Cellular Senescence The induction of a persistent G 1 arrest in the face of tein levels.
To assess whether AMPK immunoprecipitated from the continued ability to undertake translation and cell growth is a hallmark of cellular senescence. Recent eviglucose-deprived cells can phosphorylate p53, we performed an in vitro AMPK kinase assay using a GST-p53 dence has associated a progressive bioenergetic compromise with this process (Zwerschke et al., 2003). To fusion protein containing the N terminus of mouse p53 (amino acids 1-98) as a substrate (Canman et al., 1998).
assess the influence of AMPK activity on replicative senescence, constitutively active (CA-AMPK) and doWild-type AMPK but not the dominant-negative mutant could induce the phosphorylation of the p53 fragment minant-negative (DN-AMPK) mutants of AMPK were introduced into low-passage primary MEFs by retroviral-( Figure 6F ). This AMPK-induced phosphorylation was only observed using wild-type p53 sequence as submediated gene transfer, and the infected cells were subjected to serial passage following a modified 3T3 strate. A p53 substrate containing a serine to alanine substitution at position 18 failed to be phosphorylated.
protocol. Growth curves of the infected MEFs demonstrated that elevated AMPK activity induced a premaWhile these data cannot rule out the possibility that p53 is directly phosphorylated by an AMPK-associated kiture proliferative arrest in primary MEFs, while suppression of AMPK activity extended replicative life span nase that coimmunoprecipitates with AMPK, they demonstrate that AMPK kinase activity triggered by ( Figure 7A ). p53 has been implicated as a critical component of glucose deprivation promotes p53 phosphorylation specifically at serine 15 (serine 18 of mouse p53). the senescence program (Itahana et al., 2001 ). Given the link established between AMPK and p53, the inTo confirm that AMPK activity is required for p53 phosphorylation under conditions of glucose limitation, volvement of AMPK in the replicative senescence of primary MEFs lacking p53 was examined. Constitutively wild-type or dominant-negative AMPK was cotransfected into H1299 cells along with full-length mouse active AMPK was introduced into p53 +/− or p53 −/− MEFs, and growth curves for each genotype were established p53, and then the cells were subjected to low-glucose was transfected into 293T cells, and cells were subjected to low-glucose conditions 24 hr posttransfection. AMPK was immunoprecipitated from lysates using anti-myc antibodies and used to phosphorylate recombinant substrates in vitro. Recombinant GST fusion proteins expressing amino acids 1-98 of mouse p53 (GST-p53(1-98) ) or containing a serine to alanine mutation at amino acid 18 (GST-p53 S18A(1-98)) were used to assess phosphorylation of p53 by AMPK. GST-fusion proteins expressing SAMS peptide (GST-SAMS) or containing a mutation at the phosphate acceptor site (GST-SAMS M ) were used to control for AMPK activity. Recombinant proteins incorporating 
